Tower Research Capital (TRC)’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,605
Closed -$877K 5415
2026
Q1
$877K Buy
11,605
+2,991
+35% +$225K 0.02% 593
2025
Q4
$642K Sell
8,614
-4,584
-35% -$335K 0.02% 694
2025
Q3
$891K Buy
13,198
+9,150
+226% +$607K 0.02% 561
2025
Q2
$264K Buy
4,048
+1,157
+40% +$69.4K 0.01% 1536
2025
Q1
$179K Sell
2,891
-13,780
-83% -$913K 0.01% 1431
2024
Q4
$1.2M Buy
16,671
+11,377
+215% +$889K 0.02% 543
2024
Q3
$431K Sell
5,294
-7,176
-58% -$574K 0.01% 969
2024
Q2
$926K Buy
12,470
+5,191
+71% +$389K 0.02% 821
2024
Q1
$567K Sell
7,279
-40,955
-85% -$3.05M 0.01% 796
2023
Q4
$3.45M Buy
48,234
+35,614
+282% +$2.48M 0.04% 350
2023
Q3
$876K Buy
12,620
+5,639
+81% +$426K 0.03% 591
2023
Q2
$565K Sell
6,981
-2,419
-26% -$198K 0.02% 889
2023
Q1
$758K Sell
9,400
-11,359
-55% -$914K 0.02% 585
2022
Q4
$1.55M Sell
20,759
-157
-0.8% -$11.2K 0.06% 227
2022
Q3
$1.35M Sell
20,916
-1,373
-6% -$95.1K 0.02% 574
2022
Q2
$1.54M Sell
22,289
-20,412
-48% -$1.52M 0.03% 465
2022
Q1
$3.28M Buy
42,701
+24,917
+140% +$1.79M 0.03% 430
2021
Q4
$1.36M Buy
17,784
+10,062
+130% +$740K 0.02% 548
2021
Q3
$570K Buy
7,722
+2,022
+35% +$152K 0.01% 891
2021
Q2
$380K Sell
5,700
-23,713
-81% -$1.59M 0.01% 1405
2021
Q1
$2.19M Buy
29,413
+16,579
+129% +$1.26M 0.04% 450
2020
Q4
$934K Sell
12,834
-1,597
-11% -$113K 0.03% 560
2020
Q3
$959K Sell
14,431
-434
-3% -$27.5K 0.01% 1043
2020
Q2
$847K Sell
14,865
-3,422
-19% -$168K 0.03% 633
2020
Q1
$642K Buy
+18,287
New +$871K 0.04% 345
2019
Q4
Sell
-5,213
Closed -$263K 3869
2019
Q3
$263K Buy
5,213
+5,149
+8,045% +$253K 0.02% 866
2019
Q2
$3K Sell
64
-6,953
-99% -$322K ﹤0.01% 3143
2019
Q1
$339K Buy
7,017
+2,997
+75% +$135K 0.02% 857
2018
Q4
$165K Buy
+4,020
New +$165K 0.01% 758
2018
Q3
Sell
-9,133
Closed -$363K 3971
2018
Q2
$363K Sell
9,133
-9,309
-50% -$358K 0.02% 784
2018
Q1
$689K Buy
18,442
+14,136
+328% +$571K 0.06% 324
2017
Q4
$184K Sell
4,306
-5,696
-57% -$227K 0.02% 593
2017
Q3
$367K Buy
+10,002
New +$404K 0.03% 381
2017
Q2
Sell
-2,583
Closed -$114K 3020
2017
Q1
$110K Sell
2,583
-1,036
-29% -$42.2K 0.01% 439
2016
Q4
$145K Sell
3,619
-846
-19% -$32.6K 0.02% 779
2016
Q3
$173K Buy
4,465
+2,742
+159% +$104K 0.02% 549
2016
Q2
$60K Sell
1,723
-9,118
-84% -$316K 0.01% 1433
2016
Q1
$374K Buy
10,841
+10,780
+17,672% +$376K 0.06% 219
2015
Q4
$2K Buy
61
+24
+65% +$934 ﹤0.01% 3740
2015
Q3
$1K Sell
37
-1,304
-97% -$51.7K ﹤0.01% 3619
2015
Q2
$51K Buy
1,341
+140
+12% +$4.9K ﹤0.01% 1348
2015
Q1
$40K Sell
1,201
-3,398
-74% -$104K ﹤0.01% 1650
2014
Q4
$123K Sell
4,599
-2,600
-36% -$67.1K 0.01% 502
2014
Q3
$175K Sell
7,199
-2,214
-24% -$55.9K 0.02% 585
2014
Q2
$239K Buy
9,413
+5,659
+151% +$132K 0.03% 526
2014
Q1
$81K Buy
+3,754
New +$81K 0.01% 818
2013
Q4
Sell
-1,394
Closed -$29K 4659
2013
Q3
$29K Buy
1,394
+1,094
+365% +$23.3K ﹤0.01% 2399
2013
Q2
$6K Buy
+300
New +$6.27K ﹤0.01% 2801

Other funds holding HOLX

Tower Research Capital (TRC)'s HOLX Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Hologic (HOLX) in Q2 2026, closing a stake of 11,605 shares — an estimated $877K sold.

Tower Research Capital (TRC) first reported a position in HOLX in Q2 2013 and held it in 48 quarters. The position peaked at $3.45M in Q4 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 11,605 Hologic shares in Q2 2026, an estimated $877K.
  • Tower Research Capital (TRC) first reported a position in Hologic in Q2 2013 and held it in 48 quarters.
  • Tower Research Capital (TRC)'s Hologic position peaked at $3.45M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.